Perbedaan Multitrend Indo Tbk dan Brigit Biofarmaka Teknologi Tbk.: Multitrend Indo Tbk diperdagangkan di Rp174 (kapitalisasi pasar 485,32 M, volume 24 jam 589,3 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp244 (kapitalisasi pasar 164,65 M, volume 24 jam 214,9 rb). Perbedaan utamanya: Multitrend Indo Tbk jauh lebih besar — sekitar 2,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Multitrend Indo Tbk lebih aktif diperdagangkan (589,3 rb vs 214,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BABY | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 485,32 M | 164,65 M |
Volume | 589,3 rb | 214,9 rb |
Lot | 5,89 rb | 2,15 rb |
Perputaran | 101,82 jt | 51,97 jt |
Harga Rata-rata | 172,78 | 241,85 |
Nilai Transaksi | 101,82 jt | 51,97 jt |
Harga Ekuilibrium Indikatif | 174 | 240 |
Volume Ekuilibrium Indikatif | 60 | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Selengkapnya di halaman BABY →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →